Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis

Autoimmunity

Volumn 41, Issue 1, 2008, Pages 92-99

  Oertelt Prigione, Sabine ^a,b   Mao, Tin ^a   Selmi, Carlo ^a,c   Tsuneyama, Koichi ^d   Ansari, Aftab A ^e   Coppel, Ross L ^f   Invernizzi, Pietro ^b   Podda, Mauro ^b   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MONASH UNIVERSITY   (Australia)

Author keywords

Autoimmune cholangitis; Cellular immunity; Triptophan; Tumor growth factor

Indexed keywords

GAMMA INTERFERON ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; FEMALE; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELLS, CULTURED; DOWN-REGULATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; LIVER; LIVER CIRRHOSIS, BILIARY; MONOCYTES; RABBITS; TRANSFORMING GROWTH FACTOR BETA;

EID: 38049033923     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701619730     Document Type: Article

References (43)

1. Mellor, AL and Munn, DH (2004) IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol, 4, pp. 762-774.
2. Moffett, JR and Namboodiri, MA (2003) Tryptophan and the immune response. Immunol Cell Biol, 81, pp. 247-265.
3. Lan, RY, Cheng, C., Lian, ZX, Tsuneyama, K., Yang, GX and Moritoki, Y. (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology, 43, pp. 729-737.
4. Irie, J., Wu, Y., Wicker, LS, Rainbow, D., Nalesnik, MA and Hirsch, R. (2006) NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med, 203, pp. 1209-1219.
5. Oertelt, S., Lian, ZX, Cheng, CM, Chuang, YH, Padgett, KA and He, XS (2006) Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol, 177, pp. 1655-1660.
6. Wakabayashi, K., Lian, ZX, Moritoki, Y., Lan, RY, Tsuneyama, K. and Chuang, YH (2006) IL-2 receptor alpha (-/-) mice and the development of primary biliary cirrhosis. Hepatology, 44, pp. 1240-1249.
7. Munn, DH, Shafizadeh, E., Attwood, JT, Bondarev, I., Pashine, A. and Mellor, AL (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med, 189, pp. 1363-1372.
8. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F. and Falorni, A. (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol, 3, pp. 1097-1101.
9. Pemberton, LA, Kerr, SJ, Smythe, G. and Brew, BJ (1997) Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha and IFN-alpha. J Interferon Cytokine Res, 17, pp. 589-595.
10. Carlin, JM, Borden, EC, Sondel, PM and Byrne, GI (1989) Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol, 45, pp. 29-34.
11. Yuan, W., Collado-Hidalgo, A., Yufit, T., Taylor, M. and Varga, J. (1998) Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: Selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J Cell Physiol, 177, pp. 174-186.
12. MacKenzie, CR, Gonzalez, RG, Kniep, E., Roch, S. and Daubener, W. (1999) Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv Exp Med Biol, 467, pp. 533-539.
13. Thomas, SR, Mohr, D. and Stocker, R. (1994) Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J Biol Chem, 269, pp. 14457-14464.
14. Martinez, OM, Villanueva, JC, Gershwin, ME and Krams, SM (1995) Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology, 21, pp. 113-119.
15. Sanz-Cameno, P., Medina, J., Garcia-Buey, L., Garcia-Sanchez, A., Borque, MJ and Martin-Vilchez, S. (2002) Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol, 37, pp. 723-729.
16. Neuman, M., Angulo, P., Malkiewicz, I., Jorgensen, R., Shear, N. and Dickson, ER (2002) Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol, 17, pp. 196-202.
17. Agarwal, K., Jones, DE, Daly, AK, James, OF, Vaidya, B. and Pearce, S. (2000) CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol, 32, pp. 538-541.
18. Oertelt, S., Kenny, TP, Selmi, C., Invernizzi, P., Podda, M. and Gershwin, ME (2005) SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol, 12, pp. 259-263.
19. Racanelli, V. and Rehermann, B. (2006) The liver as an immunological organ. Hepatology, 43, pp. S54-S62.
20. Munn, DH, Sharma, MD, Lee, JR, Jhaver, KG, Johnson, TS and Keskin, DB (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science, 297, pp. 1867-1870.
21. Li, MO, Wan, YY, Sanjabi, S., Robertson, AK and Flavell, RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol, 24, pp. 99-146.
22. Grainger, DJ, Heathcote, K., Chiano, M., Snieder, H., Kemp, PR and Metcalfe, JC (1999) Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet, 8, pp. 93-97.
23. Kaplan, MM and Gershwin, ME (2005) Primary biliary cirrhosis. N Engl J Med, 353, pp. 1261-1273.
24. Ludwig, J., Dickson, ER and McDonald, GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol, 379, pp. 103-112.
25. LaRusso, NF, Shneider, BL, Black, D., Gores, GJ, James, SP and Doo, E. (2006) Primary sclerosing cholangitis: Summary of a workshop. Hepatology, 44, pp. 746-764.
26. NIH Consensus Statement on Management of Hepatitis C: 2002 (2002) NIH Consens State Sci Statements, 19, pp. 1-46.
27. Hucke, C., MacKenzie, CR, Adjogble, KD, Takikawa, O. and Daubener, W. (2004) Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: Inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun, 72, pp. 2723-2730.
28. Laich, A., Neurauter, G., Widner, B. and Fuchs, D. (2002) More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem, 48, pp. 579-581.
29. Steckel, NK, Kuhn, U., Beelen, DW and Elmaagacli, AH (2003) Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: Association with the induction of allogeneic immune tolerance?. Scand J Immunol, 57, pp. 185-191.
30. Quaranta, S., Shulman, H., Ahmed, A., Shoenfeld, Y., Peter, J. and McDonald, GB (1999) Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol, 91, pp. 106-116.
31. Bellucci, R., Oertelt, S., Gallagher, M., Li, S., Zorn, E. and Weller, E. (2007) Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis. Blood, 109, pp. 2001-2007.
32. Shirey, KA, Jung, JY, Maeder, GS and Carlin, JM (2006) Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells. J Interferon Cytokine Res, 26, pp. 53-62.
33. Zegarra-Moran, O., Folli, C., Manzari, B., Ravazzolo, R., Varesio, L. and Galietta, LJ (2004) Double mechanism for apical tryptophan depletion in polarized human bronchial epithelium. J Immunol, 173, pp. 542-549.
34. Gressner, AM, Weiskirchen, R., Breitkopf, K. and Dooley, S. (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci, 7, pp. 793-807.
35. Saperstein, LA, Jirtle, RL, Farouk, M., Thompson, HJ, Chung, KS and Meyers, WC (1994) Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology, 19, pp. 412-417.
36. Kita, H., Naidenko, OV, Kronenberg, M., Ansari, AA, Rogers, P. and He, XS (2002) Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology, 123, pp. 1031-1043.
37. Brusko, TM, Wasserfall, CH, Agarwal, A., Kapturczak, MH and Atkinson, MA (2005) An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+regulatory T cells. J Immunol, 174, pp. 5181-5186.
38. Wood, KJ and Sawitzki, B. (2006) Interferon gamma: A crucial role in the function of induced regulatory T cells in vivo. Trends Immunol, 27, pp. 183-187.
39. Munn, DH, Sharma, MD, Hou, D., Baban, B., Lee, JR and Antonia, SJ (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest, 114, pp. 280-290.
40. Wesierska-Gadek, J., Penner, E., Battezzati, PM, Selmi, C., Zuin, M. and Hitchman, E. (2006) Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology, 43, pp. 1135-1144.
41. Aoki, CA, Roifman, CM, Lian, Z-X, Bowlus, CL, Norman, GL, Shoenfeld, Y., Mackay, IR and Gershwin, ME (2006) IL-receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun, 27, pp. 50-53.
42. Rieger, R., Leung, PSC, Jeddelob, MR, Kurth, MJ, Nantz, MH, Lam, KS, Barsky, D., Ansari, AA, Coppel, RL, Mackay, IR and Gershwin, ME (2006) Identification of 2-nonyoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun, 27, pp. 7-16.
43. Rieger, R. and Gershwin, ME (2007) The X and Y of xenobiotics in primary biliary cirrhosis. J Autoimmun, 28, pp. 76-84.